10 May 2022 : Original article
Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
DOI: 10.12659/AOT.936162
Ann Transplant 2022; 27:e936162